liposomed heat-inactivated mycobacterium tuberculosis bacilli
Vaccineexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
2
Phase 4
0
Earliest trial started Jul 30, 2020 (NCT04453488)
Timeline
Indications
Mechanism of action
- Mycobacterium tuberculosisImmunity, active
Mycobacterium tuberculosis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05455112 | Phase 2 | Aug 31, 2022 | Archivel Farma S.L. |
| NCT05136833 | Phase 2 | Dec 31, 2021 | Archivel Farma S.L., Badalona Hospital Germans Trias i Pujol |
| NCT05115019 | Phase 2/Phase 3 (Phase 3) | Dec 31, 2021 | Archivel Farma S.L., Innovative Pharma Solutions |
| NCT04903184 | Phase 2 | Dec 9, 2020 | Archivel Farma S.L. |
| NCT04453488 | Phase 3 | Jul 30, 2020 | Badalona Hospital Germans Trias i Pujol |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Archivel Farma S.L. | For profit | 4 | 3 | 2 | 2020 |
| Badalona Hospital Germans Trias i Pujol | Academic/Hospital | 2 | 1 | 2 | 2020 |
| Innovative Pharma Solutions | For profit | 1 | 1 | 1 | 2021 |
3 organizations
Page 1 / 1